Response Biomedical – RAMP 200
The RAMP® 200 by Response Biomedical is a cutting-edge point-of-care device designed to streamline acute care diagnostic testing.
28Feb
11Feb
Inpeco – Sample Collection Solution
Enhancing Sample Collection with Inpeco’s ProTube™ Suite
In the realm of modern medicine, the accuracy and reliability of clinical laboratory results are paramount. These results significantly influence patient diagnosis, treatment, and overall health management. To ensure high-quality outcomes, it is essential to start with high-quality samples. This is where Inpeco’s ProTube™ Suite comes into play, revolutionising the pre-pre-analytical phase of sample collection.
13Jan
Sebia – To see or not A1c? On-demand Webinar
Revisit Sebia’s Educational Webinar on HbA1c Utilisation: Key Insights from Updated Lab Guidelines
We are excited to invite you to revisit Sebia’s educational webinar, “To See or Not A1c? HbA1c Utilization in Light of Recent Lab Guidelines,” presented by Dr. Matthew C. Wagner, Scientific Affairs Specialist at Sebia. This webinar is a must-watch for laboratory professionals and clinicians involved in diabetes care and management.
09Dec
Response Biomedical – RAMP NT-proBNP Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® NT-proBNP test, available on the RAMP 200 POC instrument.
09Dec
Response Biomedical – RAMP Myoglobin Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® Myoglobin test, available on the RAMP 200 POC instrument.
09Dec
Response Biomedical – RAMP D-Dimer Test
Abacus dx is pleased to introduce Response Biomedical’s rapid RAMP® D-Dimer test, available on the RAMP 200 POC instrument.
21Nov
IDS – Bone Turnover Markers
IDS Bone Turnover Markers (BTM) for use with cell culture and animal models.
When addressing changes in bone turnover at the organ or organism level, monitoring tools adequately reflecting the outcome of tissue homeostasis become particularly critical. In this context, bioassays targeting the quantification of various degradation and formation products of bone matrix elements represent a useful approach1.
25Sep
Sebia – Newborn haemoglobin disorders screening
Every day more and more newborns are screened worldwide for metabolic and endocrine disorders. Although screening for haemoglobin has a long history in some countries (USA or UK), in other countries it is a recent addition to their screening panels (Portugal; Germany).
13May
LGC Maine Standards – VALIDATE
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Linearity and calibration verification– confirmation of test stability throughout reportable ranges with VALIDATE® from Maine Standards.